Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
10/06/2011 | WO2011063129A3 Accordion bioreactor |
10/06/2011 | WO2011038373A3 Three-dimensional bioprinting of biosynthetic cellulose (bc) implants and scaffolds for tissue engineering |
10/06/2011 | WO2011016706A3 Strains of escherichia coli modified by metabolic engineering to produce chemical compounds from hydrolyzed lignocellulose, pentoses, hexoses and other carbon sources |
10/06/2011 | US20110247088 Tetracycline inducible transcription control sequence |
10/06/2011 | US20110245552 Algae processing |
10/06/2011 | US20110245318 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110245311 Histidine Derivatives |
10/06/2011 | US20110245207 Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations |
10/06/2011 | US20110245186 Recombinant e-selectin made in insect cells |
10/06/2011 | US20110245178 Exendin Fusion Proteins |
10/06/2011 | US20110245094 Detection of microbial nucleic acids |
10/06/2011 | US20110244575 Methods, systems and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp) |
10/06/2011 | US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
10/06/2011 | US20110244573 Method For The Supply Of Growth Components To Cell Cultures |
10/06/2011 | US20110244568 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators |
10/06/2011 | US20110244561 siRNA-MEDIATED GENE SILENCING |
10/06/2011 | US20110244553 Biofuel production |
10/06/2011 | US20110244548 DNA Polymerases Having Improved Labeled Nucleotide Incorporation Properties |
10/06/2011 | US20110244542 Clostridium sporosphaeroides for the treatment of biomass |
10/06/2011 | US20110244540 Preservation of Methanogenic, Hydrogen-Utilizing Microbial Cultures |
10/06/2011 | US20110244539 Selection Of Cellulolytic Microbes With High Growth Rates |
10/06/2011 | US20110244536 Fermentive production of isobutanol using highly effective ketol-acid reductoisomerase enzymes |
10/06/2011 | US20110244532 Production of branched chain fatty acids and derivatives thereof in recombinant microbial cells |
10/06/2011 | US20110244529 Process for the fermentative preparation of l -ornithine |
10/06/2011 | US20110244527 Method for producing b-glucanase and xylanase, and liquid culture medium |
10/06/2011 | US20110244525 Microorganism expressing xylose isomerase |
10/06/2011 | US20110244520 Compositions and Methods for Bacterial Production of Chondroitin |
10/06/2011 | US20110244518 Prokaryotic Expression of Soluble, Active Dkk |
10/06/2011 | US20110244517 System for antibody expression and assembly |
10/06/2011 | US20110244515 Method of preparing protein having high content of specific amino acid by co-expression with trna of specific amino acid |
10/06/2011 | US20110244514 Mammalian Sweet Taste Receptors |
10/06/2011 | US20110244513 Isolated mammalian membrane protein genes; related reagents |
10/06/2011 | US20110244512 Pentose phosphate pathway upregulation to increase production of non-native products of interest in transgenic microorganisms |
10/06/2011 | US20110244496 Hiv reverse transcriptase compositions and methods |
10/06/2011 | US20110244446 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors |
10/06/2011 | US20110243992 Methods of enhancing the immunogenicity of mycobacteria and compositions for the treatment of cancer, tuberculosis, and fibrosing lung diseases |
10/06/2011 | US20110243980 Methods and systems for o-glycosylating proteins |
10/06/2011 | US20110243976 Compositions comprising pneumococcal antigens |
10/06/2011 | US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO |
10/06/2011 | US20110243953 Neutralizing antibodies against gdf-8 and uses therefor |
10/06/2011 | US20110243930 Compositions and methods for the treatment of immune related diseases |
10/06/2011 | US20110243916 Modified endolysin ply511 |
10/06/2011 | US20110243915 Antimicrobial agents |
10/06/2011 | US20110243912 Growth Factor Binding Constructs Materials and Methods |
10/06/2011 | US20110243906 Strain of highly mosquitocidal bacillus |
10/06/2011 | US20110243905 Strain of highly mosquitocidal bacillus |
10/06/2011 | US20110243904 Rna interference target for treating aids |
10/06/2011 | US20110243888 Il-29 mutants and uses thereof |
10/06/2011 | US20110243842 Mammalian receptor proteins; related reagents and methods |
10/06/2011 | CA2794999A1 Animal feed for calves for conditioning the intestinal flora |
10/06/2011 | CA2794471A1 Novel cellulase gene |
10/06/2011 | CA2790053A1 Pentose phosphate pathway upregulation to increase production of non-native products of interest in transgenic microorganisms |
10/06/2011 | CA2775971A1 Metabolic evolution of escherichia coli strains that produce organic acids |
10/05/2011 | EP2371973A1 Method for producing sugar liquid |
10/05/2011 | EP2371962A2 Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily |
10/05/2011 | EP2371952A1 Bacterium capable of producing 2-deoxy-scyllo-inosose (doi), and process for producing 2-deoxy-scyllo-inosose (doi) by using same |
10/05/2011 | EP2371951A1 NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS |
10/05/2011 | EP2371950A1 Method for the production of cellulases based on the regulation of the oscillation of the pression of the oxygen disolved in the culture medium |
10/05/2011 | EP2371943A1 Method for washing cells |
10/05/2011 | EP2371838A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
10/05/2011 | EP2371837A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
10/05/2011 | EP2371836A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
10/05/2011 | EP2370587A1 Compositions containing docosahexaenoic acid and method for its production |
10/05/2011 | EP2370574A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation |
10/05/2011 | EP2370573A1 Fungal endoglucanases, their production and use |
10/05/2011 | EP2370572A1 Fungal endoglucanases, their production and use |
10/05/2011 | EP2370563A1 Bioprocessing ligno-cellulose into ethanol with recombinant clostridium |
10/05/2011 | EP2370475A1 Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells |
10/05/2011 | EP2370085A1 Treatment of cancer or tumor induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternative magnetic field |
10/05/2011 | EP2284261A8 Method for production of polyester copolymer using genetically modified microorganism |
10/05/2011 | EP2044194B1 Anthrax carbohydrates, synthesis and uses thereof |
10/05/2011 | EP1863921B1 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
10/05/2011 | EP1774041B1 Method for obtaining nucleic acids by lysis of microbial samples |
10/05/2011 | EP1766007B1 Non-recombinant saccharomyces strains that grow on xylose |
10/05/2011 | EP1731610B1 Proteins imparting boron-tolerance and genes thereof |
10/05/2011 | EP1727903B1 Modified xylanases exhibiting improved expression |
10/05/2011 | EP1583822B1 Methods for preserving and/or storing cells having a nitrilase or nitrile hydratase activity |
10/05/2011 | EP1495115B1 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
10/05/2011 | EP1382231B2 Method of using optical tweezers to manipulate biological materials |
10/05/2011 | EP1377680B1 Diagnosis and treatment of breast cancer based upon scn5a |
10/05/2011 | EP0975762B1 Type-1 ribosome-inactivating protein |
10/05/2011 | CN201999945U Anti-fog cell culture dish |
10/05/2011 | CN1882683B Microbe capable of producing dipeptide and process for producing dipeptide with the microbe |
10/05/2011 | CN1818052B Concentrated probiotics preparation and production thereof |
10/05/2011 | CN1639339B Fermentation process |
10/05/2011 | CN1446227B Novel fibroblast growth factor (FRF23) and method for use |
10/05/2011 | CN102209780A Improved production of riboflavin |
10/05/2011 | CN102209725A E. coli bl21 strain lacking a functional group ii capsular gene cluster |
10/05/2011 | CN102206686A Preparation method of methyl (R)-o-chloromandelate utilizing biocatalytic asymmetric reduction |
10/05/2011 | CN102206671A Method for changing characteristics of plants |
10/05/2011 | CN102206663A Nucleic acid construct containing full-length genome of human hepatitis C virus and uses |
10/05/2011 | CN102206660A Engineered protein TAT-VP28 against white spot syndrome virus of shrimp and its preparation and purpose |
10/05/2011 | CN102206659A Method for enhancing activity of endoglucanase on basis of error-prone PCR (Sequential Error-Prone) technology |
10/05/2011 | CN102206658A Alkalic xylanase gene and engineering bacterium containing same |
10/05/2011 | CN102206657A Gene and its application in treatment of quinoline contaminant |
10/05/2011 | CN102206653A High quinoline-degrading gene and application thereof |
10/05/2011 | CN102206652A Rice gel consistency control gene GC6 and application thereof |
10/05/2011 | CN102206651A Soybean cyst nematode resistance gene and application thereof |